๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-05-06
Trial ID
NCT07571551
Treatments Being Tested
The goal of this clinical research study is to learn about possible weight,...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-11-16
Trial ID
NCT02592356
This is a parallel assigned, open-label, perspective trial studying the saf...
Status
Unknown
Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2022-05-20
Trial ID
NCT05339581
The prognosis for unresectable and metastatic biliary tract cancers (BTCs) ...
Status
Completed
Location
Shanghai Jiahui International Hospital
Start Date
2021-09-15
Trial ID
NCT04550624
Treatments Being Tested
This phase II trial studies how well pembrolizumab and lenvatinib work in t...
Status
Completed
Location
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Start Date
2018-02-07
Trial ID
NCT02973997
Treatments Being Tested
This phase I trial studies the side effects and best dose of lenvatinib mes...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2016-05-27
Trial ID
NCT02788708
Treatments Being Tested
This trial is an open-label, dose-escalation, and randomized controlled Pha...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-23
Trial ID
NCT07282509
Treatments Being Tested
This research study is being done to test the efficacy and safety of combin...
Status
Active Not Recruiting
Location
University of Chicago Medicine
Start Date
2022-09-23
Trial ID
NCT05296512
Treatments Being Tested
The primary purpose of this study to continue follow-up of participants enr...
Status
Completed
Location
Eisai Trial Site #1
Start Date
2019-05-14
Trial ID
NCT04008082
Treatments Being Tested
This study is a post-marketing observational study of lenvatinib in partici...
Status
Completed
Location
Eisai trial site 1
Start Date
2018-07-02
Trial ID
NCT03663114
Treatments Being Tested